|
|
 | | | |
- close
- close
- close
- close
BioCryst Pharmaceuticals (BCRX) |
StreetInsider.com
May 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/BioCryst+Pharmaceuticals%2C+Inc.+%28BCRX%29+Posts+Q1+Loss+of+9cShare/8310290.html for the full story.
TheStreet.com
Apr 30
Comment
MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
Stocks that are making large moves like these are favorites among short-term traders...
StreetInsider.com
Apr 12
Comment
Cleantech Solutions Int. (Nasdaq: CLNT) 37.0% HIGHER; reported Q1 EPS of $0.17, versus $0.31 reported last year. Revenue for the quarter came in at $17.6 million, versus $13.7 million reported last year.
Crumbs Bake Shop, Inc. (Nasdaq: CRMB)...
StreetInsider.com
Apr 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/MLV+%26+Co.+Upgrades+BioCryst+Pharma+%28BCRX%29+to+Buy/8240454.html for the full story.
TheStreet.com
Apr 8
Comment
DURHAM, NC (TheStreet) -- BioCryst Pharmaceuticals shares are trading higher because another bird flu outbreak has hit China, leading the China State Food and Drug Administration to approve the company's injectable flu drug peramivir.
But...
Benzinga
Apr 8
Comment
Lufkin Industries Inc. (NASDAQ: LUFK) rose 38.01% to $88.23 after General Electric Co (NYSE: GE) announced its plans to buy the company for $3.3 billion in cash.
BSD Medical Corp. (NASDAQ: BSDM) jumped 31.21% to $1.85 after the company company...
Benzinga
Apr 8
Comment
Lufkin Industries (NASDAQ: LUFK) soared 37.35% to $87.81 in the pre-market trading. GE (NYSE: GE) announced its plans to buy Lufkin Industries for about $3 billion.
BioCryst Pharmaceuticals (NASDAQ: BCRX) moved up 20% to $2.04 in the pre-market...
Benzinga
Apr 5
Comment
Exide Technologies (NASDAQ: XIDE) shares rose 31.39% to $1.80 after the company announced its plans to stick with Lazard as its financial advisor.
BioCryst Pharmaceuticals (NASDAQ: BCRX) shares rose 18.94% to $1.57. BioCryst Pharmaceuticals'...
StreetInsider.com
Apr 1
Comment
Research Frontiers Inc. (Nasdaq: REFR) 31.0% HIGHER; making a strong move back above the $4 level Monday. Volum of 770,000 shares compares with the typical average of 44,000 shares.
Security National Financial Corporation (Nasdaq: SNFCA) 30.0%...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
